Lifeward Ltd. (NASDAQ:LFWD – Free Report)’s stock is scheduled to reverse split before the market opens on Tuesday, February 24th. The 1-12 reverse split was announced on Friday, February 20th. The number of shares owned by shareholders will be adjusted after the market closes on Monday, February 23rd.
Lifeward Stock Down 18.3%
Lifeward stock traded down $0.09 during trading hours on Friday, hitting $0.43. The company had a trading volume of 1,073,509 shares, compared to its average volume of 210,636. The firm’s fifty day moving average is $0.61 and its 200-day moving average is $0.63. Lifeward has a fifty-two week low of $0.40 and a fifty-two week high of $2.95.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on the stock. HC Wainwright dropped their price target on shares of Lifeward from $13.00 to $4.50 and set a “buy” rating on the stock in a research note on Tuesday, November 18th. Weiss Ratings restated a “sell (e+)” rating on shares of Lifeward in a research note on Thursday, January 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $4.25.
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in the business. Citadel Advisors LLC boosted its position in shares of Lifeward by 1,271.8% in the third quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after acquiring an additional 198,406 shares during the period. HRT Financial LP increased its position in Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after acquiring an additional 29,423 shares during the period. Finally, Jane Street Group LLC increased its position in Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after acquiring an additional 29,927 shares during the period. 26.76% of the stock is owned by institutional investors.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.
Featured Articles
- Five stocks we like better than Lifeward
- From Quiet Compounder to 2026 Breakout? BSEM
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Gilder: Don’t Buy AI Stocks, Do This Instead
- America’s 1776 happening again
- Sell this, buy that
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
